Effects of human arylamine N-acetyltransferase I knockdown in triple-negative breast cancer cell lines

Cancer Medicine

Volumn 4, Issue 4, 2015, Pages 565-574

  Tiang, Jacky M ^a   Butcher, Neville J ^a   Minchin, Rodney F ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Filopodia; Invasion; MDA MB 231; Metastasis; N acetyltransferase

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE; ARYLAMINE ACETYLTRANSFERASE 1; BETA CATENIN; CYTOKERATIN 18; NERVE CELL ADHESION MOLECULE; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR TWIST; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; CADHERIN; ISOENZYME; N-ACETYLTRANSFERASE 1; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR;

ARTICLE; BREAST CANCER CELL LINE; CELL INVASION; CELL STRUCTURE; CELL SURFACE; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LENTIVIRINAE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRIPLE NEGATIVE BREAST CANCER; TUMOR INVASION; ANIMAL; BAGG ALBINO MOUSE; CANCER TRANSPLANTATION; DEFICIENCY; ENZYMOLOGY; FEMALE; GENE SILENCING; GENETIC TRANSDUCTION; LUNG TUMOR; METABOLISM; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; PSEUDOPODIUM; SECONDARY; TUMOR CELL CULTURE; TUMOR CELL LINE;

ANIMALS; ARYLAMINE N-ACETYLTRANSFERASE; BETA CATENIN; CADHERINS; CELL LINE, TUMOR; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; ISOENZYMES; LENTIVIRUS; LUNG NEOPLASMS; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; PSEUDOPODIA; TRANSCRIPTION FACTORS; TRANSDUCTION, GENETIC; TRIPLE NEGATIVE BREAST NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 84984920648     PISSN: None     EISSN: 20457634     Source Type: Journal    
DOI: 10.1002/cam4.415     Document Type: Article

References (50)

1. Ilett, K. F., P. T. Reeves, R. F. Minchin, B. F. Kinnear, H. F. Watson, and F. F. Kadlubar 1991. Distribution of acetyltransferase activities in the intestines of rapid and slow acetylator rabbits. Carcinogenesis 12:1465-1469.
2. Minchin, R. F., P. E. Hanna, J. M. Dupret, C. R. Wagner, F. Rodrigues-Lima, and N. J. Butcher 2007. Arylamine N-acetyltransferase I. Int. J. Biochem. Cell Biol. 39:1999-2005.
3. Hein, D. W., M. A. Doll, A. J. Fretland, M. A. Leff, S. J. Webb, G. H. Xiao, et al. 2000. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol. Biomarkers Prev. 9:29-42.
4. Butcher, N. J., and R. F. Minchin 2012. Arylamine N-acetyltransferase 1: a novel drug target in cancer development. Pharmacol. Rev. 64:147-165.
5. Sinclair, J. C., J. Sandy, R. Delgoda, E. Sim, and M. E. Noble 2000. Structure of arylamine N-acetyltransferase reveals a catalytic triad. Nat. Struct. Biol. 7:560-564.
6. Sim, E., M. Payton, M. Noble, and R. Minchin 2000. An update on genetic, structural and functional studies of arylamine N-acetyltransferases in eucaryotes and procaryotes. Hum. Mol. Genet. 9:2435-2441.
7. Butcher, N. J., A. Arulpragasam, and R. F. Minchin 2004. Proteasomal degradation of N-acetyltransferase 1 is prevented by acetylation of the active site cysteine: a mechanism for the slow acetylator phenotype and substrate-dependent down-regulation. J. Biol. Chem. 279:22131-22137.
8. Dairou, J., J. M. Dupret, and F. Rodrigues-Lima 2005. Impairment of the activity of the xenobiotic-metabolizing enzymes arylamine N-acetyltransferases 1 and 2 (NAT1/NAT2) by peroxynitrite in mouse skeletal muscle cells. FEBS Lett. 579:4719-4723.
9. Dairou, J., N. Atmane, F. Rodrigues-Lima, and J. M. Dupret 2004. Peroxynitrite irreversibly inactivates the human xenobiotic-metabolizing enzyme arylamine N-acetyltransferase 1 (NAT1) in human breast cancer cells: a cellular and mechanistic study. J. Biol. Chem. 279:7708-7714.
10. Atmane, N., J. Dairou, A. Paul, J. M. Dupret, and F. Rodrigues-Lima 2003. Redox regulation of the human xenobiotic metabolizing enzyme arylamine N-acetyltransferase 1 (NAT1). Reversible inactivation by hydrogen peroxide. J. Biol. Chem. 278:35086-35092.
11. Ragunathan, N., J. Dairou, B. Pluvinage, M. Martins, E. Petit, N. Janel, et al. 2008. Identification of the xenobiotic-metabolizing enzyme arylamine N-acetyltransferase 1 as a new target of cisplatin in breast cancer cells: molecular and cellular mechanisms of inhibition. Mol. Pharmacol. 73:1761-1768.
12. Malka, F., J. Dairou, N. Ragunathan, J. M. Dupret, and F. Rodrigues-Lima 2009. Mechanisms and kinetics of human arylamine N-acetyltransferase 1 inhibition by disulfiram. FEBS J. 276:4900-4908.
13. Tiang, J. M., N. J. Butcher, and R. F. Minchin 2010. Small molecule inhibition of arylamine N-acetyltransferase type I inhibits proliferation and invasiveness of MDA-MB-231 breast cancer cells. Biochem. Biophys. Res. Commun. 393:95-100.
14. Adam, P. J., J. Berry, J. A. Loader, K. L. Tyson, G. Craggs, P. Smith, et al. 2003. Arylamine N-acetyltransferase-1 is highly expressed in breast cancers and conveys enhanced growth and resistance to etoposide in vitro. Mol. Cancer Res. 1:826-835.
15. Dolled-Filhart, M., L. Ryden, M. Cregger, K. Jirstrom, M. Harigopal, R. L. Camp, et al. 2006. Classification of breast cancer using genetic algorithms and tissue microarrays. Clin. Cancer Res. 12:6459-6468.
16. Andres, S. A., G. N. Brock, and J. L. Wittliff 2013. Interrogating differences in expression of targeted gene sets to predict breast cancer outcome. BMC Cancer 13:326.
17. Kim, S. J., H. S. Kang, S. Y. Jung, S. Y. Min, S. Lee, S. W. Kim, et al. 2010. Methylation patterns of genes coding for drug-metabolizing enzymes in tamoxifen-resistant breast cancer tissues. J. Mol. Med. (Berl) 88:1123-1131.
18. Huberts, D. H. E. W., and I. J. van der Klei 2010. Moonlighting proteins: an intriguing mode of multitasking. Biochim. Biophys. Acta 1803:520-525.
19. Hao, Z., G. S. Duncan, C. C. Chang, A. Elia, M. Fang, A. Wakeham, et al. 2005. Specific ablation of the apoptotic functions of cytochrome C reveals a differential requirement for cytochrome C and Apaf-1 in apoptosis. Cell 121:579-591.
20. Hu, S., Z. Xie, A. Onishi, X. Yu, L. Jiang, J. Lin, et al. 2009. Profiling the human protein-DNA interactome reveals ERK2 as a transcriptional repressor of interferon signaling. Cell 139:610-622.
21. Kabuyama, Y., E. S. Litman, P. D. Templeton, S. I. Metzner, E. S. Witze, G. M. Argast, et al. 2009. A mediator of Rho-dependent invasion moonlights as a methionine salvage enzyme. Mol. Cell Proteomics 8:2308-2320.
22. Ding, Y., and C. E. Lawrence 2003. A statistical sampling algorithm for RNA secondary structure prediction. Nucleic Acids Res. 31:7280-7301.
23. Tiang, J. M., N. J. Butcher, C. Cullinane, P. O. Humbert, and R. F. Minchin 2011. RNAi-mediated knock-down of arylamine N-acetyltransferase-1 expression induces E-cadherin up-regulation and cell-cell contact growth inhibition. PLoS One 6:e17031.
24. Butcher, N. J., N. L. Tetlow, C. Cheung, G. M. Broadhurst, and R. F. Minchin 2007. Induction of human arylamine N-acetyltransferase type I by androgens in human prostate cancer cells. Cancer Res. 67:85-92.
25. Goldblatt, E. M., E. R. Gentry, M. J. Fox, S. M. Gryaznov, C. Shen, and B. S. Herbert 2009. The telomerase template antagonist GRN163L alters MDA-MB-231 breast cancer cell morphology, inhibits growth, and augments the effects of paclitaxel. Mol. Cancer Ther. 8:2027-2035.
26. McSherry, E. A., S. Donatello, A. M. Hopkins, and S. McDonnell 2007. Molecular basis of invasion in breast cancer. Cell. Mol. Life Sci. 64:3201-3218.
27. Gunasinghe, N. P., A. Wells, E. W. Thompson, and H. J. Hugo 2012. Mesenchymal-epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer. Cancer Metastasis Rev. 31:469-478.
28. Sahai, E. 2005. Mechanisms of cancer cell invasion. Curr. Opin. Genet. Dev. 15:87-96.
29. Hazan, R. B., G. R. Phillips, R. F. Qiao, L. Norton, and S. A. Aaronson 2000. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J. Cell Biol. 148:779-790.
30. Derycke, L. D., and M. E. Bracke 2004. N-cadherin in the spotlight of cell-cell adhesion, differentiation, embryogenesis, invasion and signalling. Int. J. Dev. Biol. 48:463-476.
31. Chiang, C. H., M. F. Hou, and W. C. Hung 2013. Up-regulation of miR-182 by beta-catenin in breast cancer increases tumorigenicity and invasiveness by targeting the matrix metalloproteinase inhibitor RECK. Biochim. Biophys. Acta 1830:3067-3076.
32. Emami, K. H., C. Nguyen, H. Ma, D. H. Kim, K. W. Jeong, M. Eguchi, et al. 2004. A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected]. Proc. Natl. Acad. Sci. USA 101:12682-12687.
33. Li, H., D. K. Price, and W. D. Figg 2007. ADH1, an N-cadherin inhibitor, evaluated in preclinical models of angiogenesis and androgen-independent prostate cancer. Anticancer Drugs 18:563-568.
34. Minchin, R. F. 1995. Acetylation of p-aminobenzoylglutamate, a folic acid catabolite, by recombinant human arylamine N-acetyltransferase and U937 cells. Biochem. J. 307(Pt 1):1-3.
35. Witham, K. L., N. J. Butcher, K. S. Sugamori, D. Brenneman, D. M. Grant, and R. F. Minchin 2013. 5-methyl-tetrahydrofolate and the S-adenosylmethionine cycle in C57BL/6J mouse tissues: gender differences and effects of arylamine N-acetyltransferase-1 deletion. PLoS One 8:e77923.
36. Lacroix, M., and G. Leclercq 2004. Relevance of breast cancer cell lines as models for breast tumours: an update. Breast Cancer Res. Treat. 83:249-289.
37. Lehmann, B. D., J. A. Bauer, X. Chen, M. E. Sanders, A. B. Chakravarthy, Y. Shyr, et al. 2011. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J. Clin. Invest. 121:2750-2767.
38. Schlosshauer, P. W., S. A. Brown, K. Eisinger, Q. Yan, E. R. Guglielminetti, R. Parsons, et al. 2000. APC truncation and increased beta-catenin levels in a human breast cancer cell line. Carcinogenesis 21:1453-1456.
39. Kenny, P. A., G. Y. Lee, C. A. Myers, R. M. Neve, J. R. Semeiks, P. T. Spellman, et al. 2007. The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression. Mol. Oncol. 1:84-96.
40. Tubiana, M., M. H. Pejovic, S. Koscielny, N. Chavaudra, and E. Malaise 1989. Growth rate, kinetics of tumor cell proliferation and long-term outcome in human breast cancer. Int. J. Cancer 44:17-22.
41. Yang, J., and R. A. Weinberg 2008. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev. Cell 14:818-829.
42. Gao, M. Q., B. G. Kim, S. Kang, Y. P. Choi, H. Park, K. S. Kang, et al. 2010. Stromal fibroblasts from the interface zone of human breast carcinomas induce an epithelial-mesenchymal transition-like state in breast cancer cells in vitro. J. Cell Sci. 123:3507-3514.
43. Maret, D., E. Gruzglin, M. S. Sadr, V. Siu, W. Shan, A. W. Koch, et al. 2010. Surface expression of precursor N-cadherin promotes tumor cell invasion. Neoplasia 12:1066-1080.
44. Schmalhofer, O., S. Brabletz, and T. Brabletz 2009. E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev. 28:151-166.
45. Mogilner, A., and B. Rubinstein 2005. The physics of filopodial protrusion. Biophys. J. 89:782-795.
46. Machesky, L. M. 2008. Lamellipodia and filopodia in metastasis and invasion. FEBS Lett. 582:2102-2111.
47. De Wever, O., W. Westbroek, A. Verloes, N. Bloemen, M. Bracke, C. Gespach, et al. 2004. Critical role of N-cadherin in myofibroblast invasion and migration in vitro stimulated by colon-cancer-cell-derived TGF-beta or wounding. J. Cell Sci. 117:4691-4703.
48. Sadoul, K., J. Wang, B. Diagouraga, and S. Khochbin 2011. The tale of protein lysine acetylation in the cytoplasm. J. Biomed. Biotechnol. 2011:970382.
49. Kim, S. C., R. Sprung, Y. Chen, Y. Xu, H. Ball, J. Pei, et al. 2006. Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol. Cell 23:607-618.
50. Sugamori, K. S., S. Wong, A. Gaedigk, V. Yu, H. Abramovici, R. Rozmahel, et al. 2003. Generation and functional characterization of arylamine N-acetyltransferase Nat1/Nat2 double-knockout mice. Mol. Pharmacol. 64:170-179.